Birdwatch Archive

Birdwatch Note

2024-10-27 05:19:52 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

接種前に乳がんを発症し、10ヶ月後に亡くなったとのことです。 がんの生存率は原発部位、ステージ、年齢、その他により変わります。 例えば、乳がんステージ4の1年生存率は74%程度であり、10ヶ月後に亡くなることは珍しくありません https://www.kch.kagoshima.jp/sp-gan-data-seizon/ https://www.gan.med.kyushu-u.ac.jp/result/breast_cancer/index7 http://mamma.med.u-tokai.ac.jp/sp/main02/chapter03-02-06.html https://ganjoho.jp/reg_stat/statistics/data/cohort/index.html 通常のがんの進行による死亡では説明のつかない事情は一切説明されていません。 よって、この事例は「mRNAワクチンの中止を強く求めます」の根拠になりません。 日本を含めた世界中の継続かつ徹底した科学的検証でもワクチンによる被害は全くないか、極めて稀である可能性が高いと言えます https://www.mhlw.go.jp/content/10900000/000796742.pdf https://www.niid.go.jp/niid/ja/others.html https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-vaccines-safety https://doi.org/10.1016/S1473-3099(22)00320-6 https://warp.ndl.go.jp/info:ndljp/pid/13123205/www.cov19-vaccine.mhlw.go.jp/qa/0081.html https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/vaccine_qa.html#29 https://www.mhlw.go.jp/stf/shingi/shingi-kousei_284075.html

Written by EE7192EF0B1C47D8A3430C3E070DA2A0BFAA58717F9133404318E9D7666B1A00
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1850334436975673354

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1850407043368403277
  • noteId - 1850407043368403277
  • participantId -
  • noteAuthorParticipantId - EE7192EF0B1C47D8A3430C3E070DA2A0BFAA58717F9133404318E9D7666B1A00 Participant Details
  • createdAtMillis - 1730006392696
  • tweetId - 1850334436975673354
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 1
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 1
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • 接種前に乳がんを発症し、10ヶ月後に亡くなったとのことです。 がんの生存率は原発部位、ステージ、年齢、その他により変わります。 例えば、乳がんステージ4の1年生存率は74%程度であり、10ヶ月後に亡くなることは珍しくありません https://www.kch.kagoshima.jp/sp-gan-data-seizon/ https://www.gan.med.kyushu-u.ac.jp/result/breast_cancer/index7 http://mamma.med.u-tokai.ac.jp/sp/main02/chapter03-02-06.html https://ganjoho.jp/reg_stat/statistics/data/cohort/index.html 通常のがんの進行による死亡では説明のつかない事情は一切説明されていません。 よって、この事例は「mRNAワクチンの中止を強く求めます」の根拠になりません。 日本を含めた世界中の継続かつ徹底した科学的検証でもワクチンによる被害は全くないか、極めて稀である可能性が高いと言えます https://www.mhlw.go.jp/content/10900000/000796742.pdf https://www.niid.go.jp/niid/ja/others.html https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-vaccines-safety https://doi.org/10.1016/S1473-3099(22)00320-6 https://warp.ndl.go.jp/info:ndljp/pid/13123205/www.cov19-vaccine.mhlw.go.jp/qa/0081.html https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/vaccine_qa.html#29 https://www.mhlw.go.jp/stf/shingi/shingi-kousei_284075.html

Note Ratings

rated at rated by
2024-10-29 02:41:41 -0500 Rating Details
2024-10-27 09:48:25 -0500 Rating Details
2024-10-27 08:45:57 -0500 Rating Details
2024-10-27 06:26:15 -0500 Rating Details
2024-10-27 03:46:54 -0500 Rating Details
2024-10-27 03:39:45 -0500 Rating Details
2024-10-27 03:21:16 -0500 Rating Details
2024-10-27 02:46:40 -0500 Rating Details
2024-10-27 02:02:27 -0500 Rating Details
2024-10-27 01:25:15 -0500 Rating Details
2024-10-27 01:23:28 -0500 Rating Details
2024-10-27 01:07:47 -0500 Rating Details
2024-10-27 01:04:55 -0500 Rating Details
2024-10-27 00:54:43 -0500 Rating Details
2024-10-27 00:22:20 -0500 Rating Details
2024-11-01 16:40:03 -0500 Rating Details
2024-10-27 14:43:02 -0500 Rating Details
2024-10-27 08:35:30 -0500 Rating Details
2024-10-27 06:37:57 -0500 Rating Details
2024-10-27 05:43:04 -0500 Rating Details
2024-10-27 05:28:35 -0500 Rating Details
2024-10-27 05:25:48 -0500 Rating Details
2024-10-27 03:28:49 -0500 Rating Details
2024-10-27 02:51:02 -0500 Rating Details
2024-10-27 02:06:31 -0500 Rating Details
2024-10-27 02:05:28 -0500 Rating Details
2024-10-27 01:14:36 -0500 Rating Details
2024-10-27 01:14:22 -0500 Rating Details
2024-10-27 01:03:37 -0500 Rating Details
2024-10-27 01:01:24 -0500 Rating Details
2024-10-27 00:56:35 -0500 Rating Details
2024-10-27 00:49:07 -0500 Rating Details
2024-10-27 00:43:51 -0500 Rating Details
2024-10-27 00:39:17 -0500 Rating Details
2024-10-28 01:47:51 -0500 Rating Details
2024-10-27 09:16:17 -0500 Rating Details
2024-10-27 08:49:39 -0500 Rating Details
2024-10-27 06:46:21 -0500 Rating Details
2024-10-27 04:49:21 -0500 Rating Details
2024-10-27 04:45:39 -0500 Rating Details
2024-10-27 03:59:27 -0500 Rating Details
2024-10-27 03:59:05 -0500 Rating Details
2024-10-27 02:16:41 -0500 Rating Details
2024-10-27 01:56:23 -0500 Rating Details
2024-10-27 01:46:08 -0500 Rating Details
2024-10-27 01:45:00 -0500 Rating Details
2024-10-27 01:32:27 -0500 Rating Details
2024-10-27 01:10:13 -0500 Rating Details
2024-10-27 01:08:27 -0500 Rating Details
2024-10-27 01:08:05 -0500 Rating Details
2024-10-27 00:50:12 -0500 Rating Details
2024-10-27 00:23:49 -0500 Rating Details
2024-11-07 02:35:00 -0600 Rating Details
2024-10-27 08:43:34 -0500 Rating Details
2024-10-27 06:42:25 -0500 Rating Details
2024-10-27 05:03:31 -0500 Rating Details
2024-10-27 04:41:06 -0500 Rating Details
2024-10-27 02:54:21 -0500 Rating Details
2024-10-27 02:31:55 -0500 Rating Details
2024-10-27 01:59:10 -0500 Rating Details
2024-10-27 01:48:24 -0500 Rating Details
2024-10-27 01:46:14 -0500 Rating Details
2024-10-27 01:30:24 -0500 Rating Details
2024-10-27 01:27:01 -0500 Rating Details
2024-10-27 01:16:19 -0500 Rating Details
2024-10-27 01:13:26 -0500 Rating Details
2024-10-27 00:55:22 -0500 Rating Details
2024-10-27 00:52:34 -0500 Rating Details
2024-10-27 00:49:20 -0500 Rating Details
2024-10-27 00:48:23 -0500 Rating Details
2024-10-27 00:46:44 -0500 Rating Details
2024-10-27 00:43:51 -0500 Rating Details
2024-10-27 00:39:11 -0500 Rating Details
2024-10-27 00:37:18 -0500 Rating Details
2024-10-27 00:35:55 -0500 Rating Details
2024-10-27 00:34:11 -0500 Rating Details
2024-10-27 00:31:28 -0500 Rating Details
2024-10-27 00:21:44 -0500 Rating Details
2024-11-02 21:48:02 -0500 Rating Details
2024-10-28 14:58:41 -0500 Rating Details
2024-10-28 11:19:17 -0500 Rating Details
2024-10-27 11:41:43 -0500 Rating Details
2024-10-27 03:15:35 -0500 Rating Details
2024-10-27 03:02:58 -0500 Rating Details
2024-10-27 02:41:49 -0500 Rating Details
2024-10-27 02:19:20 -0500 Rating Details
2024-10-27 01:54:33 -0500 Rating Details
2024-10-27 01:49:25 -0500 Rating Details
2024-10-27 01:30:31 -0500 Rating Details
2024-10-27 01:16:29 -0500 Rating Details
2024-10-27 01:10:28 -0500 Rating Details
2024-10-27 01:04:38 -0500 Rating Details
2024-10-27 01:03:58 -0500 Rating Details
2024-10-27 00:53:10 -0500 Rating Details
2024-10-27 00:50:40 -0500 Rating Details
2024-10-27 00:49:55 -0500 Rating Details
2024-10-27 00:49:47 -0500 Rating Details
2024-10-27 00:47:57 -0500 Rating Details
2024-10-27 00:46:09 -0500 Rating Details
2024-10-27 00:44:43 -0500 Rating Details
2024-10-27 00:41:31 -0500 Rating Details
2024-10-27 00:38:19 -0500 Rating Details
2024-10-27 00:36:52 -0500 Rating Details
2024-10-27 00:36:24 -0500 Rating Details
2024-10-27 00:32:51 -0500 Rating Details